Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Article

J App Pharm Sci. 2018; 8(12): 157-164


In silico evaluation of Benzo (f) chromen-3-one as a potential inhibitor of NF-╬║B: A Key regulatory molecule in Inflammation-mediated pathogenesis of Diabetes, Alzheimerĺs and Cancer

Sandeep Kumar Gandham, Venkata Ramaiah Chintha, Rajendra Wudayagiri.

Abstract
This study is aimed to evaluate the impact of Benzo (f) chromen-3-one, a plant compound present in Artemisia vulgaris, which was retrieved from pubchem database, as a NF-╬║B inhibitor, a key regulator found to be chronically activated in various ailments, such as Cancer, Diabetes, Rheumatoid Arthritis, Alzheimers and Inflammation etc. Molecular properties of the compound were analysed using Molinspiration and Swiss ADME servers. Molecular docking studies were performed followed by pathway analysis using STRING and KEGG databases. Docking results indicate grater binding affinity of the compound with NF-╬║B molecule. Molecular properties of the compound are in agreement with the Lipinski rule of five and also possess good pharmacological properties. Pathway analyses clarify the connecting link between various ailments in inflammation induced disease pathogenesis. Our computational analysis rationalizes the inhibitory ability of naturally occurring plant compound to alter the NF-╬║B signalling pathway. Docking studies substantiates the hypothesis that Benzo (f) chromen-3-one has significant potential to inhibit the NF-╬║B.

Key words: Benzo (f) chromen-3-one, NF-╬║B, Molecular docking, inflammation.



Share this Article


Advertisement
Journal of Interdisciplinary Histopathology

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ę ScopeMed« Information Services.